Synuclein expression in the lizard Anolis carolinensis by Toni, Mattia et al.
1 
 
 1 
 2 
Synuclein expression in the lizard Anolis carolinensis 3 
 4 
Mattia Toni 1*, Carla Cioni 1, Federica De Angelis 1 and Maria Carmela Bonaccorsi di Patti 2  5 
 6 
 7 
 8 
1 Department of Biology and Biotechnology “Charles Darwin”, Sapienza University, 00161 Rome, Italy  9 
2 Department of Biochemical Sciences, Sapienza University, 00185 Rome, Italy 10 
 11 
* Author to whom correspondence should be addressed; E-Mail: mattia.toni@uniroma1.it; 12 
Tel.: +39 0649918005, Fax: +39 064457516. 13 
 14 
 15 
Abstract 16 
 17 
The synuclein (syn) family comprises three proteins: α-, β- and γ- syns. In humans they are involved in 18 
neurodegenerative diseases such as Parkinson's disease and in tumors. 19 
Members of the syn family were sequenced in representative species of all vertebrates and the comparative 20 
analysis of amino acid sequences suggests that syns are evolutionarily conserved, but information about their 21 
expression in vertebrate lineages is still scarce and completely lacking in reptiles.  22 
In this study the expression of genes coding for α-, β- and γ- syns was analyzed in the green lizard Anolis 23 
carolinensis by semiquantitative RT-PCR and Western blot.  24 
Results demonstrate good expression levels of the three syns in the lizard nervous system, similarly to human 25 
syns. This, together with the high identity between lizard and human syns, suggests that these proteins fulfill 26 
evolutionarily conserved functions. However, differences between lizard and humans in the expression of syn variants 27 
(two different variants of γ-syn were detected in A. carolinensis) and differences in some amino acids in key positions 28 
for the regulation of protein conformation and affinity for lipid and metal ions also suggest these proteins may have 29 
acquired different functional specializations in the two lineages.  30 
 31 
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 1 
Abbreviations 2 
 3 
 4 
aa   amino acid 5 
Br  brain  6 
Bs  brainstem  7 
Ce  cerebellum  8 
CNS  central nervous system 9 
CT  C-terminal 10 
Di  diencephalon 11 
Ey  eye 12 
He  heart 13 
In  intestine 14 
Li  liver 15 
Lu  lung  16 
Mu  muscle 17 
MW  Molecular Weight 18 
NAC   non-β amyloid component 19 
NT  N-terminal 20 
nt  nucleotide 21 
NTr  N-terminal region 22 
OT  midbrain tectum 23 
pI  isoelectric point 24 
PD  Parkinson's disease  25 
R  rat brain 26 
RT-PCR reverse transcriptase-polymerase chain reaction 27 
SC  spinal cord 28 
syn   synuclein 29 
Te  telencephalon 30 
 31 
 32 
33 
3 
 
Introduction 1 
The synuclein (syn) family comprises naturally unfolded proteins with a molecular weight (MW) of about 15-20 kDa 2 
that are specifically expressed in neurons of vertebrates (George et al. 1995; Jakes et al. 1994; Maroteaux and Scheller 3 
1991). The first syn was discovered in the electric ray Torpedo californica (Maroteaux et al. 1988) but afterwards 4 
homologous proteins were identified in mammals (Akopian and Wood 1995; Jakes et al. 1994; Ji et al. 1997; Lavedan 5 
et al. 1998a; Tobe et al. 1992; Ueda et al. 1993) and in other vertebrates (George et al. 1995; Sun and Gitler 2008; 6 
Tiunova et al. 2000; Wang et al. 2011).  7 
Synucleins in mammals are encoded by three genes that map on different chromosomes: snca coding for α-syn, 8 
sncb for β-syn and sncg for γ-syn (Campion et al. 1995; Lavedan et al. 1998a,b; Shibasaki et al. 1995; Spillantini et al. 9 
1995). Human syn genes are composed of five coding exons of similar size (Lavedan 1998) and four different α-syn 10 
isoforms are produced by alternative splicing of snca (Beyer and Ariza 2013). 11 
The biological functions of syns are still poorly understood. These proteins are involved in neurodegenerative 12 
diseases known as synucleinopathies (mainly α- and β- syns) and in some tumors (γ-syn). Synucleinopathies, which 13 
include Parkinson's disease (PD), dementia with Lewy bodies, PD dementia, multiple system atrophy, and neuroaxonal 14 
dystrophies (Dikiy and Eliezer 2012; Irwin et al. 2013; Luk and Lee 2014; Moore et al. 2005; Norris et al. 2004; 15 
Pfefferkorn et al. 2012), are characterized by the intracellular accumulation of proteinaceous bodies containing α-syn 16 
aggregates that lead to neurodegeneration (Spillantini 1999). α-syn is directly involved in PD since modifications of the 17 
snca gene such as single nucleotide polymorphisms (Maraganore et al. 2006; Pals et al. 2004; Pankratz et al. 2009; 18 
Rajput et al. 2009), missense mutations, duplications (Chartier-Harlin et al. 2004; Ibanez et al. 2004) and triplications 19 
(Singleton et al. 2003) have been associated with an increased risk for this disease. Moreover, α-syn post-translational 20 
modifications such as ubiquitination, nitration and phosphorylation (Giasson et al. 2000; Tofaris et al. 2003; Xilouri and 21 
Stefanis 2011) may promote the formation of the pathological inclusions.  22 
Among synucleins, α-syn has been the most studied protein for its direct involvement in PD. The primary 23 
structure of human α-syn is commonly divided into N-terminal (NT) (1-60 residues), non-β amyloid component (NAC) 24 
(61-95 residues) and C-terminal (CT) (96-140 residues) regions. The N-terminus contains the amino acids involved in 25 
all the PD-related mutations (A30P, E46K, H50Q, G51D and A53T) identified so far (Appel-Cresswell et al. 2013; 26 
Conway et al. 1998; El-Agnaf et al. 1998; Hamilton 2004; Jensen et al. 1998; Kruger et al. 1998; Lesage et al. 2013; 27 
Mbefo et al. 2015; Narhi et al. 1999; Proukakis et al. 2013; Rospigliosi et al. 2009; Yonetani et al. 2009). NAC is a 28 
highly hydrophobic region that is directly involved in the formation of amyloid fibrils and characterized by the amino 29 
acid stretch GVTAVAQKTVE. This sequence is missing in β-syn and only partially conserved in γ-syn and is able to 30 
acquire a β-sheet structure when α-syn forms fibrils (Weinreb et al. 1996). The NT and NAC regions include the seven 31 
semi-conserved repeats of 11 residues containing the apolipoprotein lipid-binding motif [EGS]-K-T-K-[EQ]-[GQ]-V-32 
XXXX that allows α-syn to acquire α-helix structure and bind to lipid membranes. Finally, the C-terminus is a 33 
negatively charged unstructured region proposed to act as a scaffold to recruit additional proteins to the membranes 34 
(Eliezer et al. 2001) and that contains low-affinity binding sites for metal ions such as Fe(II), Mn(II), Co(II) and Ni(II) 35 
(Binolfi et al. 2006; Lu et al. 2011). The binding of metals to syns can have important effects on the conformation and 36 
properties of the protein. For example, the binding of Cu(II) to α-syn induced the multimerization of the protein (Paik et 37 
al. 1999) and the incubation of α-syn with Mn(II) resulted in the formation of dityrosine cross-links (Uversky et al. 38 
2001) that could lead to the initiation of α-syn fibrillization. The majority of α-syn post-translational modifications 39 
(truncation, phosphorylation, methionine oxidation, and nitration) occur within this region that contains 40 
phosphorylatable serines (S87 and S129) and tyrosines (Y125, Y133, and Y136). 41 
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In mammals, α-syn can adopt different secondary structures, folding into an α-helix or β-sheet structure on 1 
the surrounding environment, and it is likely that the protein exists in multiple conformations in a living cell. In fact, 2 
evidence shows that wild-type α-syn contains little α-helix (3%) and β-sheet (23%), whereas the rest of the protein 3 
assumes a random conformation (Davidson et al. 1998; Weinreb et al. 1996). However, upon the binding of NT and 4 
NAC region to small phospholipid vesicles, the protein largely folds in an α-helical conformation (63–71% of the 5 
protein) (Davidson et al. 1998). On the other hand, α-syn in some conditions can change to an anti-parallel β-sheet 6 
conformation (El-Agnaf et al. 1998; Narhi et al. 1999; Weinreb et al. 1996) and readily assembles into filaments. 7 
Evidence suggests that α-syn functions may be related to its ability to interact directly with membrane 8 
phospholipids (Iwai et al. 1995), proteins (Dunker et al. 2005) and metals (Lu et al. 2011). In particular α-syn has been 9 
implicated in vesicle trafficking during neurotransmitter release (Burre et al. 2010; Chandra et al. 2005), synaptic 10 
vesicle pool maintenance (Abeliovich et al. 2000), synaptic plasticity (Zarranz et al. 2004) and learning (George et al. 11 
1995). On the other hand, γ-syn has been involved in tumor pathogenesis and it correlates with adverse outcomes in 12 
some cancers (Bruening et al. 2000; Hibi et al. 2009; Ji et al. 1997; Liu et al. 2010, 2012). Moreover, experimental 13 
studies showed that γ-syn over-expression stimulates cell proliferation (Jia et al. 1999) and increases the invasiveness of 14 
breast tumor cells (Jia et al. 1999). 15 
According to the percentage of sequence identity with mammalian isoforms,  non-mammalian syns were 16 
classified as α-syn, β-syn or γ-syn. However, there is a great variability in the number of non-mammalian isoforms  due 17 
to the existence of additional genes encoding for β- and γ- syns in the vertebrate genome. In particular,  four syn genes 18 
were described in Xenopus laevis and Takifugu rubripes due to the presence of two β-syn genes (sncba and sncbb) in 19 
the first (Wang et al. 2011) and two γ-syn genes (sncga and sncgb) in the latter (Yoshida et al. 2006). Moreover, the 20 
absence of snca was demonstrated in the genome of the zebrafish Danio rerio which consequently possesses only three 21 
syn genes (sncb, sncga and sncgb) (Milanese et al. 2012; Sun and Gitler 2008). Moreover, non mammalian syns were 22 
identified having scarce similarity to the three main isoforms,  named by progressive numbers,  i.e.  “synuclein 3” of 23 
lamprey (Busch and Morgan 2012) or generically “synuclein-like” protein. 24 
The genome sequencing of representative species from main vertebrate taxa has recently led to an increase in 25 
the number of available nucleotide (nt) and amino acid (aa) sequences for syns. These data suggested a still higher 26 
variability in syn isoforms of non-mammalian vertebrates due to the existence  of β- and γ- syn variants named X1, X2 27 
and X3. However, further analyses are needed to assess the actual expression of these isoforms in animal tissues (Toni 28 
and Cioni 2015). 29 
The comparative analysis of syn sequences showed a high degree of conservation among vertebrates (George 30 
et al. 1995; Jakes et al. 1994; Maroteaux and Scheller 1991; Yuan and Zhao 2013) suggesting conserved physiological 31 
functions for these proteins. Among non mammalian vertebrates, the study of syn gene expression in both embryo 32 
(Chen et al. 2009; Sun and Gitler 2008; Tiunova et al. 2000; Wang et al. 2011), larval (Busch and Morgan 2012) and 33 
adult (Maroteaux et al. 1988; Yoshida et al. 2006) animals showed a different spatiotemporal expression pattern of syn 34 
isoforms with a prevalent expression of α- and β- syns in the central nervous system (CNS) and of γ-syns in the 35 
peripheral nervous system (Milanese et al. 2012; Tiunova et al. 2000; Wang et al. 2011). Among non mammalian 36 
vertebrates, syn gene expression was analyzed in the embryo of fish (Danio rerio, (Chen et al. 2009; Milanese et al. 37 
2012)), amphibians (Xenopus laevis, (Wang et al. 2011)) and birds (Gallus gallus (Tiunova et al. 2000)) and these 38 
studies showed similarities in the embryonic expression pattern of syn genes suggesting that syns may have conserved 39 
functions in nervous system development (Milanese et al. 2012; Tiunova et al. 2000; Wang et al. 2011). To date no 40 
studies on syn expression in reptiles are available.  41 
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For this reason, we have studied the syn expression in the green lizard Anolis carolinensis which was chosen 1 
as a study model because of the availability of the whole genome sequence of this species and for the ready 2 
availability of specimens from local authorized providers. In this study, nt and aa syn sequences deduced from the 3 
lizard genome were analyzed and compared with human syn sequences. Moreover, gene and protein expression of 4 
lizard syns were evaluated in the CNS and non nervous organs by semi-quantitative RT-PCR and Western blotting. This 5 
work is part of a larger study started some years ago by our research group that aims to gain new information about syns 6 
in non-mammalian vertebrates, in order to obtain data useful to understand the evolution and the physiological functions 7 
of these proteins and to develop new models of PD, as alternatives to mammals (Toni and Cioni 2015; Vaccaro et al. 8 
2015).  9 
 10 
 11 
Materials and methods 12 
 13 
 14 
Animals and sampling  15 
 16 
12 adult individuals of Anolis carolinensis (Taxon 28377), obtained from local authorized providers (Tropicalia, 17 
Florence, Italy) were used. Animals were sacrificed by an intra-peritoneal injection of a lethal dose (20 mg) of sodium 18 
thiopental (Intervet, Italy) and several, nervous and non nervous, organs (brain, spinal cord, eye, muscle, heart, 19 
intestine, liver and lung) were quickly removed. Brains were further subdivided into the following samples: 20 
telencephalon, diencephalon, midbrain tectum, cerebellum and brainstem. For each brain region, tissues collected from 21 
6 animals were pooled together in a single sample in order to have sufficient biological material to perform the 22 
analysis. One sample (derived from 6 animals) was successively analyzed by semi quantitative RT-PCR to evaluate syn 23 
gene expression and the other sample by Western blot to analyze syn protein expression. Tissues were kept in RNA 24 
Later (Ambion, Austin, TX) at -70°C until they were processed.  25 
 26 
Sequence analysis 27 
 28 
The nt and aa sequences of lizard syns were sought in the NCBI protein database (http://www.ncbi.nlm.nih.gov/protein, 29 
RRID:nif-0000-03178). A total of 3 genes (snca, sncb and sncg), 5 nucleotide mRNA sequences and 4 deduced aa 30 
sequences defined by different Accession Numbers were detected (Table 1). The comparative analysis of aa sequences 31 
was performed using the Clustal Omega software (http://www.ebi.ac.uk/Tools/msa/clustalo/). For human isoforms, the 32 
aa sequences of α- (Accession Number P37840.1), β- (AN AAB30860.1) and γ- (AN NP_003078.2) syns were used. 33 
The phosphorylation site predictions were performed using the NetPhosK 1.0 Server at 34 
http://www.cbs.dtu.dk/services/NetPhosK/ (Blom et al. 2004) and the secondary structure predictions of lizard proteins 35 
were obtained by The PSIPRED Protein Sequence Analysis Workbench at http://bioinf.cs.ucl.ac.uk/psipred/ (Jones 36 
1999). 37 
 38 
RNA extraction and RT-PCR analysis 39 
 40 
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Total RNA was extracted from the samples previously collected using Trizol reagent (Invitrogen) for whole brain and 1 
organ samples and ReliaPrep™ RNA Tissue Miniprep System kit (Promega) for the brain regions according to the 2 
manufacturer’s protocol. About one microgram total RNA of each sample was reverse transcribed using SuperScript® 3 
II Reverse Transcriptase kit (Invitrogen). After reverse transcription, 100 ng of each cDNA were used as template for 4 
polymerase chain reaction (PCR) amplifications.  PCR was performed using Bioline Master Mix and specific primers 5 
for synucleins (α-, β-, and γ- syns) (Table 2) and glyceraldehyde3-phosphate dehydrogenase (GAPDH) (final 6 
concentration 1 µM). PCR conditions were initial denaturation at 94° C for 2 min; 30/35 cycles with the following 7 
profile, 94° C for 30 s, 60°C for 30 s, 72°C for 45 s; final extension at 72°C for 5 min. For each PCR reaction, 12.5µl 8 
was run on 1.6% agarose gel. GAPDH was used to normalize the intensity of the amplified bands. For the evaluation of 9 
X1 and X2 γ-syn expression, RT-PCR with primers X1 and X2 (Table 2) was carried out on 0.5 µg total RNA with the 10 
Access RT-PCR System (Promega) according to the manufacturer’s instructions. 11 
 12 
Antibodies 13 
 14 
As no commercial antibodies against lizard syns were available, antibodies against mammalian proteins able to 15 
recognize lizard isoforms were sought in order to perform Western blot analysis. The characteristics of about 20 16 
antibodies, whose datasheet clearly reported information on the recognized epitopes, were first evaluated to assay their 17 
putative ability to recognize and discriminate lizard syns. Among these, the following antibodies were tested in Western 18 
blot experiments on lizard sample. For α-syn immuno-detection two non commercial (2E3 and 3D5) and three 19 
commercial antibodies were tested: 1) 2E3 (RRID:AB_2315787, Department of Neurobiology, Xuanwu Hospital, 20 
Capital Medical University Cat# 2E3) directed against the epitope DMPVDPD (115-121 in human α-syn), 2) 3D5 21 
(RRID:AB_2315791, Department of Neurobiology, Xuanwu Hospital,Capital Medical University Cat# 3D5), directed 22 
against the epitope QDYEP (amino acids 134-138 in human α-syn) (Yu et al., 2007) and previously used on carp brain 23 
(Vaccaro et al. 2015); 3) a rabbit polyclonal antibody against the 111-131 region of human α-syn (Millipore AB5038, 24 
RRID:AB_91648); 4) a mouse monoclonal antibody against the 115-122 region of human α-syn (ab27766, Abcam); 5) 25 
a mouse monoclonal antibody against the 15-123 region of rat α-syn (610787, BD Transduction Laboratories) that 26 
recognizes the epitope ATGFVKKDQ situated between residues 91 and 99 of rat α-syn (Perrin et al. 2003). For β-syn 27 
immunodetection, a mouse monoclonal antibody raised against amino acids 107-118 of rat β-syn (sc-136452, Santa 28 
Cruz) was tested.  29 
The antibodies were tested by Western blot analysis on homogenates of lizard and rat brain (data not shown) 30 
and the two antibodies with the best performances in terms of labeling specificity, lower number of immuno-labeled 31 
bands and reduced or absent background were used in the following analysis. The following antibodies were selected 32 
and used in subsequent experiments: the mouse monoclonal antibody against the 15-123 region of rat α-syn (610787, 33 
BD Transduction Laboratories) diluted at 1:500 and the mouse monoclonal antibody raised against amino acids 107-118 34 
of rat β-syn (sc-136452, Santa Cruz) diluted 1:200.  35 
A commercial β-actin antibody (Santa Cruz Biotechnology sc-47778, RRID:AB_626632) was used to 36 
normalize Western blot results. The anti mouse peroxidase-conjugated antibody diluted at 1:5000 (Sigma-Aldrich 37 
A9044, RRID:AB_25843) was used as secondary antibody. 38 
 39 
Western blot experiments 40 
 41 
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Samples previously collected and constituted from tissues pooled from 6 animals were homogenized in a denaturing 1 
lysis buffer containing 30 mM Tris/HCl (pH 7.4), 1.5% sodium dodecyl sulfate (SDS, w/v), 8 mM EDTA (v/v) and 50 2 
mM dithiothreitol (DTT, v/v) (Yang et al. 2014) and protease inhibitors (Roche, Germany); then the particulate matter 3 
was removed by centrifugation at 14000 g for 20 min. The protein concentration was determined by the Bradford assay. 4 
For SDS-PAGE analysis, proteins were denatured by boiling in Laemmli Sample Buffer for 5 min. Then 50 µg of 5 
protein was loaded in each lane and separated in 15 % SDS-polyacrylamide gels according to Laemmli (Laemmli 6 
1970). After electrophoresis, gels were transferred to nitrocellulose paper (Hybond C+ Extra, GE Healthcare, UK) and 7 
membranes were stained with Ponceau S to confirm the transfer of proteins. The saturation step was performed by 8 
incubating membranes in 5% bovine serum albumin (BSA) in TBS-Tween for 2 hours at room temperature (Vaccaro et 9 
al. 2015).  10 
Normalization was made against β-actin expression detected by β-actin antibody (Santa Cruz Biotechnology sc-47778, 11 
RRID:AB_626632) diluted at 1:3,000. Rat brain homogenates were used as positive controls and negative controls were 12 
performed by the omission of primary antibodies. Detection was done using the Westar µC Ultra enhanced 13 
chemiluminescent HRP substrate (Cyanagen, Italy) and Kodak X Omat LS films (Sigma-Aldrich, USA). The developed 14 
films were scanned as Tiff images in 8-bit gray scale format at setting of 300 dpi and the band intensities were 15 
measured by Image J software (U.S. National Institutes of Health, Maryland). In electrophoresis experiments, the 16 
“Amersham Full-Range Rainbow MW Markers (12–225 KDa)” were used.  17 
 18 
Results 19 
 20 
Synuclein genes and protein expression  21 
 22 
The information on the nt and aa sequences of Anolis carolinensis syns present in the NCBI database consisted of 23 
sequences predicted by automated computational analysis of lizard genomic sequences annotated using the Gnomon 24 
gene prediction method. In the genome of A. carolinensis three different genes encoding syn proteins were identified: 25 
snca (Gene ID: 100 563 343), sncb (Gene ID: 100 559 889) and sncg (Gene ID: 100 561 651) (Table 1).  26 
The snca gene is located on chromosome 5 [position NC_014780.1 (46219523…46294230)] and consists of 27 
six exons, the first of which is totally non-coding (Fig. 1). The predicted mRNA coding for α-syn (XM_003221301.2) 28 
consisted of 1693 nt with a 429 nt-long coding sequence (CDS) (662-1090 nt) (Fig. 1). The predicted α-syn aa sequence 29 
(XP_003221349.1) corresponded to a protein of 142 residues with a predicted MW of 14921 Da and an isoelectric point 30 
(pI) of 4.56. 31 
The sncb gene (Gene ID: 100 559 889) consisted of six exons and its location has not yet been determined 32 
according to the present genome assembly (AnoCar2.0) (Fig. 2). In the NCBI database two different variants of the 33 
mRNA encoded by sncb gene were present: X1 (XM_008121117.1) and X2 (XM_003227782.2) variants of β-syn, 34 
constituted by 1453 and 1542 nt, respectively (Fig. 2 and Table 1). The differences between the two mRNA isoforms 35 
were restricted to the first non-coding exons and so the two β-syn mRNA variants had an identical CDS (296-697 nt in 36 
X1 and 385-786 nt in X2) and they coded for the same aa sequence (XP_008119324.1 for X1 and XP_003227830.1 for 37 
X2). The β-syn corresponded to a predicted protein of 133 aa with MW 14000 Da and pI 4.42. 38 
The sncg gene (Gene ID: 100 561 651) consisted of five exons and its location has not yet been identified (Fig. 39 
3). In the NCBI database, two different mRNA variants of γ-syn named X1 (XM_008114475.1) and X2 40 
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(XM_008114476.1) were present. X1 γ-syn consisted of 1336 nt with a CDS of 525 nt (400-924 nt) and coded for a 1 
predicted protein (XP_008112682.1) of 174 aa with MW 18600 Da and pI 4.74. The X2 γ-syn consisted of 1182 nt, had 2 
a CDS of 399 nucleotides (372-770 nt) and encoded for a predicted protein (XP_008112683.1) of 132 aa with MW 3 
13814 Da and pI 4.46 (Fig. 3 and Table 1). The comparative analysis between the mRNA sequences of the two γ-syn 4 
variants showed that they are identical except for the insertion of a 126 nt sequence in the variant X1 caused by a 5 
different length of the fourth exon. Thus, variant X1 presents 42 additional amino acids following residue 126 in the CT 6 
region. 7 
 8 
Sequence comparison and analysis 9 
 10 
The comparative analysis performed among the aa sequences of lizard syns showed an overall identity of 66% 11 
between α- and β- syns, of 50% or 55% between α-syn and X1 or X2 γ-syns, and of 47% or 53% between β-syn and X1 12 
or X2 γ-syns (Table 3). Among lizard syns the N-terminus (aa 1-60) was more conserved than the C-terminus and the 13 
identity in the first rose to values ranging from 78% to 81% whereas in the second it decreased to values ranging from 14 
13 to 45% (Table 3 and Fig. 4a).  15 
Comparative analyses were performed between lizard and human syns to evaluate the conservation of these 16 
proteins and to verify the presence in lizard syns of conserved domains or residues associated to specific functions in 17 
mammalian syns. 18 
Lizard syns appeared well conserved when compared with the homologous human proteins (Fig. 4b-d). The 19 
percentage of identity between lizard and human syns on the whole length was 86% between α-syns, 89% between β-20 
syns and 68 and 69% between γ-syns (Table 3). In the N-terminus the identity rose to 88 and 90% respectively for α- 21 
and β- syns, and to 95% for both X1 and X2 γ-syns whereas in C-terminus the identity was 80% between α-syns, 89% 22 
between β-syns and 43 and 45% for X1 and X2 γ-syns. The identity of the NAC region betwe en lizard and human α-23 
syns was 91%. 24 
As in human α-syn some point mutations (A30P, E46K, H50Q, G51D, A53T) have been linked to PD, the 25 
conservation of these amino acids was evaluated in lizard α-syn (amino acids shown in red in Fig. 4b). In lizard α-syn 26 
alanine (A) at position 30 and glycine (G) at position 51 were conserved whereas conservative replacement of glutamic 27 
acid (E) at position 46 with aspartic acid (D) was observed (Fig. 4b). Interestingly, histidine-to-glutamine substitution 28 
(H50Q) and alanine-to-threonine substitution (A53T) were present in lizard α-syn (Fig. 4b). 29 
In the NT and NAC regions of human syns, imperfect repeats of 11 amino acids containing the apolipoproteins 30 
lipid-binding motif ([EGS]-KTK-[EQ]-[GQ]-V-XXXX) are present. These repeats were preserved in lizard syns (Table 31 
4 and Fig. 4b-d) in which seven imperfect repeats were present in α- and γ- syns and five repeats were present in β-syn 32 
(Table 4). The first 4 repeats were continuous in all isoforms and were separated from the following repeats by 3 (β-33 
syn) or 4 (α-syn, X1 and X2 γ-syns) amino acids. However, only three repeats in α-syn (II, III and V) and two in β- and 34 
γ- syns (II and III) contained the complete apolipoproteins lipid-binding motif (underlined aa stretches in Fig. 4a and in 35 
Table 4). 36 
The aa stretch GVTAVAQKTVE that in human α-syn is able to acquire a β-sheet structure when the protein 37 
aggregates in fibrils, was perfectly conserved in lizard α-syn but it was not present in β- and γ- syns, as in human β- and 38 
γ- syns (double underlined amino acids in Fig. 4a,b).  39 
The C-terminus of human α-syn, an unstructured region characterized by the presence of negative charges, can 40 
bind metal ions and it is subjected to post-translational modifications, such as phosphorylation, that may affect protein 41 
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conformation and function. The negative charge distribution was generally preserved in lizard α-syn due to the presence 1 
of 5 residues of aspartic acid (D) and 10 residues of glutamic acid (E) (bold characters in Fig. 4b).  2 
Interestingly both serines (S) located at position 87 and 129 in human α-syn (circled amino acid in Fig. 4b) that 3 
have been found to be relevant to PD were not conserved in lizard α-syn in which they were substituted by asparagine 4 
(N) and proline (P), respectively (Fig. 4b). On the contrary, other putative phosphorylation sites in human α-syn (Y125, 5 
Y133, and Y136) were perfectly conserved in the lizard protein (black arrowheads in Fig. 4b). Amino acids that in 6 
human α-syn are directly or indirectly involved in the binding of metal ions (Y39, Y125, Y133, Y136, M116 and 7 
M127) are conserved in the lizard isoform. 8 
Secondary structure prediction confirmed that the C-terminus of lizard syns is mainly an unstructured region 9 
whereas the NT and NAC regions, where the semi-conserved repeats of 11 residues containing the apolipoproteins 10 
lipid-biding motif are located, may adopt α-helical conformations (Fig. 5).  11 
 12 
Synuclein gene expression  13 
 14 
The gene expression of the syn isoforms was evaluated in the major organs of the green lizard A.carolinensis by semi-15 
quantitative RT-PCR (Fig. 6). The availability of the mRNA sequences coding for syn isoforms allowed the design of 16 
specific primers able to discriminate the expression of the different genes (Figs. 1-3).  17 
α-, β- and γ- syns were expressed both in nervous and non-nervous organs and the most intense expression was 18 
detected in the brain (Fig. 6a). In the spinal cord α- and β- syns were also intensely expressed, whereas a low expression 19 
of γ-syn was detected. Variable levels of the three syn isoforms were also detected in the eye, heart, intestine, liver and 20 
lung. β-syn was substantially expressed in the muscle where α- and γ- syn expression was very low or absent.  21 
The expression of γ-syn was further investigated by using primers able to discriminate X1 and X2 variants 22 
(Table 2 and Fig. 3) in order to evaluate whether both isoforms were expressed in the lizard. Interestingly, both X1 and 23 
X2 were expressed in the brain and spinal cord while in most of the other organs, the X2 isoform was the isoform 24 
predominantly expressed. Low or very low levels of X1 were detected in the eye, intestine and liver. 25 
Syn expression was further investigated in selected brain regions where high levels of α-, β-, and γ- syns were 26 
detected in all the brain regions analyzed and interestingly both X1 and X2 γ-syns were detected in telencephalon, 27 
diencephalon, cerebellum and brainstem (Fig. 6b). 28 
 29 
Antibody choice  30 
 31 
As described in detail in the section “Materials and methods”, a preliminary search to identify commercial antibodies 32 
directed toward mammalian syns and able to recognize and discriminate the different isoforms of lizard syns was 33 
carried out on the basis of the sequence identity of relevant epitopes. Antibodies with the most suitable characteristics 34 
for this study were tested in preliminary Western blot experiments. Among them, the two antibodies with the best 35 
performances were chosen for subsequent analyzes: the α-syn (610787, BD Transduction Laboratories) and the β-syn  36 
(sc-136452, Santa Cruz) antibody. The first is a mouse monoclonal antibody recognizing the ATGFVKKDQ epitope 37 
(Perrin et al. 2003) that is present in both rat and lizard α-syns. The same antibody showed no cross reactivity with β- 38 
and γ- syns in Western blot experiments performed in α-syn null mouse (Perrin et al. 2003). For β-syn, a mouse 39 
monoclonal antibody raised against the epitope LIEPLMEPEGES corresponding to amino acids 107-118 of rat β-syn 40 
was used. This aa stretch is well conserved in lizard β-syn. This information suggests that the chosen antibodies can be 41 
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valuable tools to study the expression of α- and β- syns in lizard. On the contrary, because of the high identity among 1 
the NT region of lizard syns and of the low identity between the CT region of lizard and mammalian γ-syn, it has not 2 
been possible to identify antibodies specific for lizard γ-syn. 3 
 4 
Synuclein protein expression  5 
 6 
The protein expression of α- and β- syns was verified in the same organs by Western blot using antibodies directed 7 
against the mammalian isoforms (Fig. 7). The main purpose of these analyses was to confirm and corroborate the data 8 
obtained from semi-quantitative RT-PCR experiments demonstrating the effective expression of syn proteins in the 9 
brain regions and organs analyzed and to provide useful tools for future localization of these proteins by means of 10 
immunohistochemical methods. 11 
The α-syn antibody revealed an intensely labeled band at about 14/16 kDa, corresponding to the predicted 12 
MW, in the brain and spinal cord while no bands were detected in the other organs analyzed (eye, muscle, heart, 13 
intestine, liver and lung) (Fig. 7b). Only longer film exposure times, leading to the signal saturation of the brain band, 14 
allowed detection of immuno-labeled bands in the eye, heart and intestine samples. Even at these exposure conditions, 15 
no defined bands were detected in the muscle and liver whereas in the lung a diffuse and undefined labeling that could 16 
correspond to a very low amount of protein or to a background of the film was detected. 17 
The protein expression analysis of β-syn showed the presence of an immuno-labeled band at about 14/16 kDa 18 
only in brain, spinal cord and eye samples (Fig. 7c). Even at higher exposure time, very faint bands were observed in 19 
the heart, intestine and lung. Given the long exposure times and the weakness of the bands it is conceivable that this 20 
labeling could be non-specific. 21 
The α- and β- syn expression was further investigated in the encephalic regions and results demonstrated that both 22 
proteins are expressed in telencephalon, midbrain tectum, diencephalon, cerebellum and brainstem (Fig. 7d, e).  23 
The densitometric analysis of syn bands normalized on actin levels showed for both α- and β- syns a 24 
substantially similar expression pattern with the highest expression levels in the telencephalon. Other brain regions 25 
(diencephalon, midbrain tectum, brainstem, and cerebellum) showed lower expression levels with the lowest levels 26 
found in the spinal cord (about 10% for α-syn and 40% for β-syn with respect to telencephalon). 27 
 28 
Discussion 29 
 30 
In this study,  syn gene and protein expression was studied  in the CNS and non nervous organs of the green 31 
lizard A. carolinensis as a representative species for reptiles. Three genes encoding for α- (snca), β- (sncb) and γ- (sncg) 32 
syns were identified in the available genome of A. carolinensis (Genome assembly, AnoCar 2.0), as  in bird and 33 
mammalian genomes (Lavedan 1998). In contrast, three (Danio rerio) (Milanese et al. 2012; Sun and Gitler 2008) to 34 
four (Takifugu rubripes) (Yoshida et al. 2006), syn genes have been detected in teleost fish, and four in anurans 35 
(Xenopus laevis) (Wang et al. 2011). This variability in the number of syn genes in fish and amphibians has been 36 
attributed to the whole genome duplication that occurred in the ray-finned fish (Actinopterygia) about 230 million 37 
years ago (Amores et al. 1998; Jaillon et al. 2004) and to the pseudotetraploid condition of X. laevis (Wang et al. 2011). 38 
In A. carolinensis the three syn genes consisted of five coding exons showing a similar organization to that 39 
previously described in fish (Yoshida et al. 2006) and humans (Lavedan 1998). The NT region of lizard syns is coded 40 
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by the first two exons, the NAC region by the third exon, and the unstructured and negatively charged C-terminus is 1 
coded by the fourth and fifth exons. Overall these data further confirm the high degree of conservation of syn genes 2 
among vertebrate species.  3 
In the NCBI database, five different lizard syn mRNAs were present as two different mRNA variants, named 4 
X1 and X2, exist for both β- and γ- syns. X1 and X2 β-syns differed only in the non-CDS and so both encoded the same 5 
aa sequence, whereas the mRNAs of X1 and X2 γ-syns encoded two proteins of different size, as X1 was characterized 6 
by the insertion of 42 residues in the CT region. Our results demonstrate that X1 and X2 γ-syn isoforms are actually 7 
both expressed in the lizard with a different regional expression pattern, suggesting that the two γ-syn variants could 8 
fulfill different and specific functions. Thus, the expression of different syn variants is not a characteristic only of 9 
mammals, where alternative splicing events produce α-syn variants (Beyer et al. 2008; Campion et al. 1995; Ueda et al. 10 
1994), but also occurs in reptiles, suggesting complex scenarios of action for syns also in this taxon. 11 
The comparative analysis between the aa sequences of human and lizard syns showed a high level of identity 12 
throughout the entire sequence, confirming the high degree of conservation among vertebrate syns. This suggests that 13 
these proteins fulfill important and conserved physiological functions in vertebrates. However, the real physiological 14 
roles of syns have not yet been fully elucidated.  15 
The aim of the present study was not to discover the physiological functions of lizard syns, but to analyze their 16 
gene and protein expression in the CNS and in the main organs. Nevertheless, the high identity between human and 17 
lizard syns and the presence of conserved regions suggest that most of syn features could be conserved in lizard, 18 
including the ability to acquire specific secondary structure and to bind lipid vesicles and metal ions. In fact, the aa 19 
stretch GVTAVAQKTVE was perfectly conserved in lizard α-syn, suggesting it might be able to fold into a β-sheet 20 
structure and to aggregate forming fibrils, as may happen in humans. Moreover, the presence in A. carolinensis of 21 
perfectly conserved apolipoproteins lipid binding motives suggests that these proteins could bind lipid membranes 22 
fulfilling related physiological functions such as vesicular trafficking and maintenance of synaptic vesicle pool. 23 
Furthermore, the conservation of some tyrosines (Y39, Y125, Y133 and Y136) and methionines (M116 and M127), 24 
suggests that human and lizard α-syns share the ability to bind metal ions.  25 
However, despite the generally high sequence identity between human and lizard α-syn, small differences in the aa 26 
sequence were observed that can affect protein function and regulation. For example, in the NT region of lizard α-syn, 27 
the histidine (H) at position 50 is replaced by a glutamine (Q), and the alanine (A) at position 53 is replaced by a 28 
threonine (T). These changes correspond exactly to the H50Q (Appel-Cresswell et al. 2013; Proukakis et al. 2013) and 29 
A53T (Larsen et al. 2009) mutations that in human α-syn are linked to PD. The H50Q was also detected in α-syn of 30 
the lobe-finned fish Latimeria chalumnae and of the emperor penguin Aptenodytes forsteri (Gruschus 2015) and 31 
this substitution was described by Proukakis and co-workers (2013) as a mutation affecting copper coordination and 32 
enhancing the stability of the α-helix domain.  33 
The A53T mutation alters human α-syn structure expanding the hydrophobic domain (from 11 to 30 aa), 34 
destabilizing the α-helical domain (Biere et al. 2000), and facilitating the folding of the protein into a β-sheet structure 35 
required for the formation of oligomeric species (Biere et al. 2000; Conway et al. 1998; Giasson et al. 1999; Hashimoto 36 
et al. 1998). The presence of threonine (T) at position 53 has been described in α-syn of several fish (Vaccaro et al. 37 
2015; Gruschus 2015), bird and mammalian species including some New World monkeys (Hamilton 2004; Gruschus 38 
2015) suggesting that, on one side, the presence of T may not affect the lifespan of short-lived vertebrates and, on the 39 
other side, that long-lived animals may have adapted alternative mechanisms to minimize toxic accumulation of α-syn 40 
oligomers. On the basis of the presence of Q50 and T53 in lizard α-syn it could be speculated that this protein may be 41 
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more prone to form aggregates. However, further experiments are necessary to confirm this hypothesis. Interestingly, a 1 
recent analysis of available vertebrate sequences of α-syn and glucocerebrosidase (GCase), including those of 2 
Anolis carolinensis, showed a correlation between PD-associated α-syn substitutions and residue substitutions in 3 
the GCase. This study suggested the co-evolution of the two proteins and provided evidence of altered α-4 
syn/GCase interaction in PD pathology (Gruschus 2015). 5 
One difference between lizard and human α-syns was the replacement in A. carolinensis of serines at position 6 
87 and 129 with asparagine and proline, respectively. These differences could have important effects on the regulation 7 
and functions of the protein as in humans the phosphorylation at S87 influences its binding to lipid membranes 8 
(Paleologou et al. 2010), and the phosphorylation at S129 regulates α-syn oligomerization, fibril formation, and 9 
neurotoxicity (Anderson et al. 2006; Fujiwara et al. 2002).  10 
With regard to the binding of metal ions, the binding sites of Cu(II), Pb(II), Fe(II) identified by Lu et al. in the 11 
CT region of human α-syn (Lu et al. 2011) are not perfectly preserved in lizard, suggesting possible differences in the 12 
affinity and in the number of divalent cations bound by human and lizard proteins. In human α-syn the binding site for 13 
copper at the N-terminus involves M1 and D2 when the metal is bound as Cu(II), or M1 and M5 when it binds as Cu(I), 14 
in the latter case also M10 in β-syn participates in metal binding (De Ricco et al. 2015a). In human α-syn a role for H50 15 
in Cu(II) coordination, acting as a molecular switch has recently been suggested (De Ricco et al. 2015b). In lizard α-16 
syn, H50 is replaced by glutamine while in β-syn M10 is substituted by lysine, further suggesting that copper-binding 17 
properties will be different. On the basis of the detected differences we can assume that α-syn may be subjected to 18 
different regulation mechanisms in reptiles and mammals. 19 
In adult specimens of the green lizard A. carolinensis, the three syn genes were expressed both in nervous and 20 
non-nervous organs suggesting a role for syns in the cell physiology of different tissues. syn gene and protein 21 
expression was particularly intense in the CNS where α-, β- and γ- syns were expressed in all the main encephalic 22 
regions, in the spinal cord and in the eye. 23 
The three syn genes were also expressed in other organs such as heart, intestine, liver and lung, while in the 24 
skeletal muscle only β-syn mRNA was expressed at detectable levels. However, it should be emphasized that even in 25 
those organs in which discrete mRNA levels were detected, the protein expression levels of α- and β- syns were scarce 26 
or at the limit of detection. This suggests the presence of post-translational regulation systems in lizard organs. 27 
Both X1 and X2 γ-syn mRNAs were expressed in the CNS, whereas X2 was the most expressed variant in non 28 
nervous organs. This suggests that X1 and X2 γ-syns may be specialized in fulfilling different roles in the lizard. The 29 
addition of 42 amino acids after residue 126 in the CT region in X1 γ-syn may affect the interactions of this protein with 30 
other molecules or its mechanisms of regulation. More focused experiments are needed to further investigate this issue. 31 
The available data on syn expression in species belonging to the different vertebrate classes are still partial and 32 
limited. Depending on the species, the gene or protein expression was analyzed by using semi-quantitative methods 33 
(Northern blot, RT-PCR and Western blot) or by analyzing the tissue/cell distribution (in situ hybridization and 34 
immunohistochemistry). For this reason, a precise comparison of syn expression in vertebrate species cannot be 35 
performed. However, even considering these limits, differences in syn gene expression can be revealed comparing 36 
lizard and other vertebrate species. In the lizard, differently from what happens in humans (Lavedan 1998), α-syn was 37 
expressed in the liver, β-syn in the liver, lung and heart, and γ-syn in the lung. On the contrary, the three syn isoforms 38 
were expressed in human skeletal muscle, whereas in the lizard only β-syn was expressed in skeletal tissue. Such 39 
differences may result from the different sensitivity of the methods used (RT-PCR and Northern blot) or may reflect 40 
real differences due to different functional specializations of syns in the different species.  41 
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The expression of syn variants in the lizard might be restricted to specific cell types, as observed in 1 
mammals. For example, α-syn is mainly expressed in central catecholaminergic neurons, whereas β-syn is more 2 
localized in cholinergic neurons in the rat CNS (Li et al., 2002). Moreover, only few neuronal populations of the 3 
human nervous system are vulnerable to the neurodegenerative process in the idiopathic PD (Braak et al., 2003). 4 
Among non neuronal tissues, α-syn is expressed by enteric neurons but not in glial cells and smooth muscle 5 
(Paillusson et al., 2010). Alpha-syn is also specifically expressed in pancreatic β-cells (Geng et al., 2001) and in 6 
chromaffin cells (Larsen et al., 2006). Similar evidence has been found in teleosts. Indeed, the expression of α-syn 7 
is mainly localized to cholinergic neurons in the carp CNS (Vaccaro et al., 2015). Therefore, the expression of syn 8 
variants in specific cell types is expected in the lizard. In situ hybridization and immunohistochemical studies 9 
will contribute to compare cellular distribution of syn variants in lizard and other vertebrates. 10 
The comparison of data recently obtained in carp (Toni and Cioni 2015; Vaccaro et al. 2015) with those of 11 
lizard shows that in both species α-syn protein is expressed in all brain regions. However, the relative expression levels 12 
among the encephalic regions is different, as in lizard the higher α-syn protein expression was detected in the 13 
telencephalon, while the same region in the carp showed a low expression. In this sense, the expression of α-syn in 14 
lizard most resembles that observed in mammals where higher levels of expression have been detected in the 15 
telencephalon and diencephalon than in the caudal brain regions (Li et al. 2002). At this regard, it may be worth 16 
mentioning that telencephalic regions of amniotes share a number of common organizational and functional features 17 
since comparative neuroanatomical studies have shown that most ascending sensory projections to the telencephalon 18 
described in mammals also occur in reptiles (Butler and Hodos, 2005).  19 
In conclusion, this paper analyzed for the first time the syn expression in the lizard A. carolinensis, selected as 20 
representative of reptiles. The results confirm that syns are evolutionarily conserved both in gene structure and in amino 21 
acid sequence. The presence in lizard syns of aa sequences that in humans are involved in the binding to lipid vesicles 22 
and to metal ions and in the formation of fibrillar aggregates suggests that these proteins may perform similar functions 23 
in reptiles and mammals. However, small differences in aa sequences, in the tissue expressional pattern and in the 24 
relative amount of proteins expressed in different tissues and brain regions, suggests that syns may have acquired 25 
functional specializations during reptile evolution. 26 
 27 
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Tables 1 
 2 
 3 
Synuclein Gene ID mRNA Protein 
α 100563343 XM_003221301.2 XP_003221349.1 
β 100559889 
XM_008121117.1(X1) 
XM_003227782.2(X2) 
XP_008119324.1 (X1) 
XP_003227830.1 (X2) 
γ 100561651 
XM_008114475.1 (X1) 
XM_008114476.1(X2) 
XP_008112682.1 (X1) 
XP_008112683.1 (X2) 
 4 
Table 1 Gene, mRNA and amino acid sequence of lizard synucleins available at the NCBI database. ID and 5 
Accession number are indicated. 6 
 7 
 8 
 9 
Primer name Sequence (5’-3’) 
α-syn_F TTCAAAGACCAGGGATGGAG 
α-syn_R CTTCATCCTGTTTGCCCAGT 
β-syn_F GGTCAAGAAAGATGAATTCCC 
β-syn_R TTCCGGCTCATATTCCTGAT 
γ-syn_F AGACATTGGCTACGCTGCAA 
γ-syn_R CCATGATGGCTTTGCTCTTG 
GAPDH_F TTTCAATGGCATGTCAAAGCA 
GAPDH_R GGACTCCACAACATAGTCTGCA 
X1 γ-syn_F GTCCAGAGGTAAAGCACAGTCA 
X2 γ-syn_F AAAGAACAGGCCAACCTCGT 
X1/X2 γ-syn_R GCTCTGGTGTCAGCTAACATTT 
 10 
Table 2 Oligonucleotide sequences used as PCR primers for the analysis of synuclein transcripts.  11 
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C NTr NAC CTr C NTr CTr C NTr CTr C NTr CTr C NTr CTr C NTr CTr 
α-syn β-syn X1 γ-syn X2 γ-syn α-syn β-syn 
A. carolinensis H. sapiens 
 1 
Table 3 Determination of the percentage identity of human and lizard syn amino acid sequences. The Clustal 2 
Omega software at http://www.ebi.ac.uk/Tools/msa/clustalo/ was used. C: complete sequence; CTr: C-terminal region; 3 
NTr: N-terminal region; NAC: non-β amyloid component. Lizard α-syn (NTr=1-60 aa, NAC=61-95 aa, CTr= 96-142 4 
aa), β-syn (NTr=1-59 aa, CTr=60-133), X1 γ-syn (NTr=1-60 aa, CTr=61-174) and X2 γ-syn (NTr=1-60 aa, CTr= 61-5 
132aa). Human α-syn (NTr=1-60  aa, NAC= 61-95 aa, CTr= 96-140), β-syn (NTr=1-60 aa, CTr= 61-134 aa); γ-syn 6 
(NTr=1-60 aa, CTr= 61-127 aa). 7 
 8 
 α synuclein β synuclein X1 and X2 γ synuclein 
I  9 NKAKDGVVAAA 19  9 SKAKEGVAAAA 19  9 SIAKEGVVAAA 19 
II 20 EKTKQGVAEAA 30 20 EKTKEGVAAAA 30 20 EKTKQGVTEAA 30 
III 31 GKTKEGVLYVG 41 31 EKTKEGVLYVG 41 31 EKTKEGVMYVG 41 
IV 42 SKTRDGVVQGV 52 42 SKTREGVAGVA 52 42 AKTKEGVVQSV 52 
V 57 EKTKEQVSNVG 67 56 EKTKEQASQLG 66 57 EKTKEQANLVG 67 
VI 68 GAVVTGVTAVA 78  68 ESVVASVNTVA 78 
VII 79 QKTVEGAGNFA 89  79 KQTVEGAETVV 89 
 9 
Table 4 Repeats in lizard synucleins. The aa sequences of repeats I-VII of α-syn (residues 9-89), repeats I-V (residues 10 
9-66) of β-syn, repeats I-VII (residues 9-97) of X1 and X2 γ-syns are shown. Conserved residues of the apolipoproteins 11 
lipid-biding motif [EGS]-K-T-K-[EQ]-[GQ]-V-XXXX are indicated in bold and repeats that contain a perfectly 12 
conserved lipid binding motif are underlined.  13 
Figure captions 14 
23 
 
 1 
Fig. 1 Alpha synuclein of Anolis carolinensis: gene structure, mRNA and protein sequence 2 
a organization of the lizard α-syn gene. Exons are represented by boxes and introns are shown as horizontal lines not 3 
drawn in scale (see inset showing the ratio line length/number of nucleotides). The non-coding regions are represented 4 
in black color whereas the coding regions of different exons are indicated by different colors (red, blue, green, orange 5 
and violet). b nt sequence of α-syn mRNA (XM_003221301.2). The regions against which the forward and reverse RT-6 
PCR primers were designed are indicated by arrows. c deduced aa sequence of lizard α-syn (XP_003221349.1). The 7 
predicted MW and pI are indicated. In b and c, sequences coded by different exons are represented with the same color 8 
code used in the schematic drawing of the gene. The exon boundaries are indicated by square brackets. 9 
 10 
Fig.2 Beta synuclein of Anolis carolinensis: gene structure, mRNA and protein sequences 11 
a organization of the lizard β-syn gene. Exons are represented by boxes and introns are shown as horizontal lines (not 12 
drawn in scale). See inset of Fig. 1 showing the ratio line length/number of nucleotides. The non-coding regions are 13 
represented in black color whereas the coding regions of different exons are indicated by different colors (red, blue, 14 
green, orange and violet). b comparative analysis of the nt sequences of the two mRNA variants of lizard β-syn 15 
available in the NCBI database (X1, XM_008121117.1; X2, XM_003227782.2). Sequences were aligned with Clustal 16 
Omega. Asterisks indicate identity of nucleotides. The regions against which the forward and reverse RT-PCR primers 17 
were designed are indicated by arrows. c deduced aa sequence of lizard β-syn (XP_008119324.1; XP_003227830.1). As 18 
X1 and X2 β-syn mRNA differ only in the non-coding region, they code the same aa sequence. The predicted MW and 19 
pI are indicated. In b and c, sequences coded by different exons are indicated with the same color code used in the 20 
schematic drawing of the gene. The numbers refer to the nt and aa positions at the end of each line. The exon 21 
boundaries are indicated by square brackets. 22 
 23 
Fig. 3 Gamma synuclein of Anolis carolinensis: gene structure, mRNA and protein sequences  24 
a organization of the lizard γ-syn gene. Exons are represented by boxes and introns are shown as horizontal lines (not 25 
drawn in scale). See the inset of Fig. 1 showing the ratio line length/number of nucleotides. The non-coding regions are 26 
represented in black color whereas the coding regions of different exons are indicated by different colors (red, blue, 27 
green, orange and violet). b comparative alignment of the nt sequences of the two mRNA variants of lizard γ-syn 28 
available in the NCBI database (X1, XM_008114475.1; X2, XM_008114476.1). The regions against which the forward 29 
and reverse RT-PCR primers were designed are indicated by arrows: red ones for γ-syn and dotted ones for X1 (green) 30 
and X2 (purple) γ-syns. c comparative alignment of the deduced aa sequences of lizard X1 and X2 γ-syns 31 
(XP_008119324.1; XP_003227830.1). The predicted MW and pI are indicated. In b and c, sequences coded by different 32 
exons are indicated with the same color code used in the schematic drawing of the gene. Sequences were aligned with 33 
Clustal Omega. Asterisks indicate identity of amino acids; double dots indicate amino acids with the same polarity or 34 
size; dots indicate semi-conserved substitutions. The numbers refer to the nt and aa positions at the end of each line. 35 
The exon boundaries are indicated by square brackets. 36 
 37 
38 
24 
 
Fig. 4 Comparative analysis of human and lizard synucleins  1 
Amino acid sequence alignment among lizard syns (a) and between human and lizard α- (b), β- (c) and γ- (d) syns are 2 
reported. a The stretches of amino acids encoded by different exons are marked with different colors and the exon 3 
boundaries are indicated by vertical lines. Conserved repeats of the apolipoproteins lipid-biding motif [EGS]-K-T-K-4 
[EQ]-[GQ]-V-XXXX are underlined (see Table 4 for details). The NAC region of α-syn is highlighted in gray. b black 5 
arrowheads indicate phosphorylatable tyrosines, arrows indicate methionines that represent binding sites for Mn(II) and 6 
other metals. The phosphorylatable serines are circled in yellow. N-terminal, C-terminal and NAC regions are indicated. 7 
Negative amino acids in the CT region are indicated in bold. The amino acids that in humans are involved in the 8 
pathological mutations linked to Parkinson’s disease are shown in red. a-d The positions of the semi-conserved repeats 9 
are indicated by the roman numbers (I-VII) above the sequences. The aa stretch GVTAVAQKTVE, which is perfectly 10 
conserved between human and lizard α-syns and that is directly involved in the formation of human amyloid fibrils, is 11 
double underlined. Sequences were aligned with Clustal Omega. Asterisks indicate identity of amino acids; double dots 12 
indicate amino acids with the same polarity or size; dots indicate semi-conserved substitutions. 13 
 14 
Fig. 5 Secondary structure prediction of lizard synucleins 15 
Prediction of the secondary structure of α-, β-, X1 and X2 γ- syns in Anolis carolinensis using the PSIPRED Protein 16 
Sequence Analysis Workbench at http://bioinf.cs.ucl.ac.uk/psipred/ (Jones 1999). The position of the semi-conserved 17 
repeats is indicated by the roman numbers (I-VII) above the sequences. The NAC region of α-syn (61-95 residues) is 18 
underlined. 19 
 20 
Fig. 6 Synuclein gene expression in the major organs of the lizard Anolis carolinensis  21 
Semi-quantitative RT-PCR analysis of syn gene expression in the main organs (a) and encephalic regions (b) of the 22 
lizard Anolis carolinensis. For γ-syn detection, both general and specific primers able to discriminate X1 and X2 23 
variants were used. Br: brain; Bs: brainstem; Ce: cerebellum; Di: diencephalon; Ey: eye; He: heart; In: intestine; Li: 24 
liver; Lu: lung; Mu: muscle; OT: midbrain tectum; SC: spinal cord; Te: telencephalon. 25 
 26 
 27 
Fig. 7 Synuclein protein expression in the major organs of the lizard Anolis carolinensis  28 
Western blot analysis of α- and β- syns in the main organs (a-c) and encephalic regions (d-f) of the lizard Anolis 29 
carolinensis. Red ponceau staining is shown in a, α-syn immunolabelling in b and d and β-syn immunolabelling in c 30 
and e. The densitometric analysis of immunolabeled bands normalized on actin levels is reported in f. Br: brain; Bs: 31 
brainstem; Ce: cerebellum; Di: diencephalon; Ey: eye; He: heart; In: intestine; Li: liver; Lu: lung; Mu: muscle; OT: 32 
midbrain tectum; R: rat brain; SC: spinal cord; Te: telencephalon. 33 
